相似文献
1
Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.
Nanomedicine (Lond). 2010 Feb;5(2):269-85. doi: 10.2217/nnm.10.1.
2
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
Biomaterials. 2013 Aug;34(26):6202-28. doi: 10.1016/j.biomaterials.2013.05.012. Epub 2013 May 28.
3
Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome.
Hum Gene Ther. 2006 Jun;17(6):577-88. doi: 10.1089/hum.2006.17.577.
4
Toward a cure - Advancing HIV/AIDs treatment modalities beyond antiretroviral therapy: A Review.
Medicine (Baltimore). 2024 Jul 5;103(27):e38768. doi: 10.1097/MD.0000000000038768.
5
Nanotechnology approaches to eradicating HIV reservoirs.
Eur J Pharm Biopharm. 2019 May;138:48-63. doi: 10.1016/j.ejpb.2018.06.002. Epub 2018 Jun 4.
6
Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.
Discov Med. 2006 Aug;6(34):157-62.
7
Clinical challenges in HIV/AIDS: Hints for advancing prevention and patient management strategies.
Adv Drug Deliv Rev. 2016 Aug 1;103:5-19. doi: 10.1016/j.addr.2016.04.016. Epub 2016 Apr 23.
8
[HIV/AIDS: the new therapeutic strategies remain a priority].
Rev Med Suisse. 2009 Nov 11;5(225):2301-2.
9
[Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
Sante. 2009 Jul-Sep;19(3):141-8. doi: 10.1684/san.2009.0169.
10
The economics of HIV/AIDS in low-income countries: the case for prevention.
J Econ Perspect. 2006 Summer;20(3):121-42. doi: 10.1257/jep.20.3.121.
引用本文的文献
1
Advances in HIV Treatment and Vaccine Development: Emerging Therapies and Breakthrough Strategies for Long-Term Control.
AIDS Res Treat. 2025 Jul 4;2025:6829446. doi: 10.1155/arat/6829446. eCollection 2025.
2
State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic.
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
3
Polymeric and lipidic nanoparticles in transforming anti-HIV combinational therapy: can they turn the tide?
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 23. doi: 10.1007/s00210-025-04169-w.
4
HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives.
Trop Med Infect Dis. 2025 Feb 5;10(2):45. doi: 10.3390/tropicalmed10020045.
5
Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections.
J Biol Methods. 2024 Oct 23;11(4):e99010032. doi: 10.14440/jbm.2024.0065. eCollection 2024.
6
Navigating Latency-Inducing Viral Infections: Therapeutic Targeting and Nanoparticle Utilization.
Biomater Res. 2024 Oct 16;28:0078. doi: 10.34133/bmr.0078. eCollection 2024.
7
Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation.
BMC Complement Med Ther. 2024 Oct 2;24(1):350. doi: 10.1186/s12906-024-04634-8.
8
Advances in the transdermal delivery of antiretroviral drugs.
SAGE Open Med. 2024 Jan 18;12:20503121231223600. doi: 10.1177/20503121231223600. eCollection 2024.
9
Drug Delivery to the Brain: Recent Advances and Unmet Challenges.
Pharmaceutics. 2023 Nov 23;15(12):2658. doi: 10.3390/pharmaceutics15122658.
10
Advances in drug delivery systems, challenges and future directions.
Heliyon. 2023 Jun 24;9(6):e17488. doi: 10.1016/j.heliyon.2023.e17488. eCollection 2023 Jun.
本文引用的文献
1
The immune response during acute HIV-1 infection: clues for vaccine development.
Nat Rev Immunol. 2010 Jan;10(1):11-23. doi: 10.1038/nri2674. Epub 2009 Dec 11.
2
Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.
Int J Nanomedicine. 2009;4:227-32. doi: 10.2147/ijn.s7814. Epub 2009 Oct 19.
3
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19268-73. doi: 10.1073/pnas.0905998106. Epub 2009 Nov 9.
4
All-trans retinoic acid potentiates the antibody response in mice to a lipopeptide antigen adjuvanted with liposomal lipid A.
Immunol Cell Biol. 2009 Nov-Dec;87(8):630-3. doi: 10.1038/icb.2009.48. Epub 2009 Jul 14.
5
NanoART, neuroAIDS and CNS drug delivery.
Nanomedicine (Lond). 2009 Jul;4(5):557-74. doi: 10.2217/nnm.09.38.
6
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.
J Immunol. 2009 Jul 1;183(1):661-9. doi: 10.4049/jimmunol.0900274. Epub 2009 Jun 17.
7
Immunotherapies in HIV-1 infection.
Curr Opin HIV AIDS. 2009 May;4(3):188-93. doi: 10.1097/COH.0b013e328329d090.
8
X-ray structures of the hexameric building block of the HIV capsid.
Cell. 2009 Jun 26;137(7):1282-92. doi: 10.1016/j.cell.2009.04.063. Epub 2009 Jun 11.
9
AIDS vaccine research and advocacy: an update.
BETA. 2009 Winter-Spring;21(2):24-30.
10
Patent life of antiretroviral drugs approved in the US from 1987 to 2007.
AIDS Care. 2009 Jun;21(6):760-8. doi: 10.1080/09540120802511950.
Zotero 插件